We also compared the frequency of pathologic features and biomarker expression of the 12 ER- and 9 ER+ BRCA1-associated cancers for which wt BRCA1 allele status could not be determined to ensure that this group was similar to those cancers which were successfully subjected to LOH analysis. This evidence concerns the gene BRCA1 and cancer.